David L Pompliano

Title: David L Pompliano: Innovator in Enzyme Assays

Introduction

David L Pompliano is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of enzyme assays, holding a total of 3 patents. His work focuses on developing innovative methods for screening enzyme inhibitors, which are crucial for various biochemical applications.

Latest Patents

One of his latest patents is the "Metabolic pathway assay," which is an in vitro screening assay designed to identify enzyme inhibitors. This assay allows for the simultaneous testing of multiple enzymes by optimizing the concentrations of enzymes, substrates, and co-factors. The goal is to ensure that inhibitors of any one enzyme in the pathway can be detected equally. The assay conditions are predicted through computer modeling, and the pathway conditions are optimized by varying the concentrations of enzymes and substrates. A positive response is indicated by a change in the amount of product generated at the end of the enzyme cascade compared to a standard.

Another significant invention is the "Fluorescence assay of Ras farnesyl protein transferase." This continuous fluorescence assay is used to screen for inhibitors of farnesyl:protein transferase and can be modified to screen for inhibitors of other protein transferases as well.

Career Highlights

David L Pompliano is currently associated with Merck & Co., Inc., where he continues to advance his research in enzyme assays. His work has been instrumental in enhancing the understanding of enzyme interactions and their inhibitors.

Collaborations

He has collaborated with notable coworkers such as Neville J Anthony and Renee M Chabin, contributing to the innovative research environment at Merck.

Conclusion

David L Pompliano's contributions to enzyme assay technology have paved the way for advancements in biochemical research and drug development. His innovative patents reflect his commitment to enhancing the field of enzymology.